Petmed Express Inc (NASDAQ:PETS) declared a quarterly dividend on Monday, May 6th, NASDAQ reports. Investors of record on Friday, May 17th will be given a dividend of 0.27 per share on Friday, May 24th. This represents a $1.08 annualized dividend and a yield of 5.99%. The ex-dividend date is Thursday, May 16th.
Petmed Express has raised its dividend by an average of 13.6% annually over the last three years and has raised its dividend every year for the last 7 years. Petmed Express has a payout ratio of 47.4% indicating that its dividend is sufficiently covered by earnings.
Shares of NASDAQ:PETS traded up $0.04 on Wednesday, hitting $18.02. 690,500 shares of the company’s stock were exchanged, compared to its average volume of 670,529. The stock has a market cap of $368.96 million, a P/E ratio of 9.90 and a beta of 0.47. Petmed Express has a 1-year low of $17.68 and a 1-year high of $46.83.
Petmed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, May 6th. The company reported $0.32 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.14). The company had revenue of $64.57 million for the quarter, compared to analysts’ expectations of $69.06 million. Petmed Express had a net margin of 13.32% and a return on equity of 28.96%. The firm’s revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.50 earnings per share.
A number of equities analysts have recently issued reports on the company. ValuEngine downgraded Petmed Express from a “hold” rating to a “sell” rating in a research note on Monday, February 4th. BidaskClub upgraded Petmed Express from a “sell” rating to a “hold” rating in a report on Wednesday, April 3rd. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company. The stock presently has a consensus rating of “Sell” and an average target price of $18.00.
TRADEMARK VIOLATION NOTICE: “Petmed Express Inc Plans Quarterly Dividend of $0.27 (PETS)” was published by Sundance Herald and is the property of of Sundance Herald. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://sundanceherald.com/2019/05/29/petmed-express-inc-pets-announces-0-27-quarterly-dividend.html.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.